HDAC6-IN-23 (compound 9) is an orally active HDAC6 inhibitor.
References:
[1]. Ripa L, et al. Selective and Bioavailable HDAC6 2-(Difluorometl)-1,3,4-oxadiazole Substrate Inhibitors and Modeling of Their Bioactivation Mechanism [published online ahead of print, 2023 Oct 5]. J Med Chem. 2023;10.1021/acs.jmedchem.3c01269.
















